Sophie Hordijk on A New Cause of the Hereditary Bleeding Disorder of VWD Type 1
Zeldzame bloedstollingsstoornissen shared on LinkedIn:
”New insights into Von Willebrand disease thanks to research
The latest issue of the Dutch Journal of Hematology features an interview with Sophie Hordijk, PhD candidate at the Department of Hematology at Erasmus MC in Ruben Bierings’ research group.
Sophie recently published a study in the leading journal Blood, in which she and her colleagues identified a new cause of the hereditary bleeding disorder Von Willebrand disease type 1.
The study points to impaired secretion of Von Willebrand Factor by endothelial cells as a possible key to a better understanding of the condition.
Curious about the scientific article?
Read it here.
Want to know more about Sophie Hordijk, Ruben Bierings, and the NTvH journal?
Take a look on LinkedIn:
- Sophie Hordijk
- Ruben Bierings
- Nederlands Tijdschrift voor Hematologie (Dutch Journal of Hematology)
Read the full interview here.”
Read the full article in Blood.
Article: A novel cause of type 1 von Willebrand disease: impaired exocytosis of Weibel-Palade bodies due to biallelic MADD variants
Authors: Sophie Hordijk, Stijn A. Groten, Petra E. Bürgisser, Sebastiaan N. J. Laan, Georg Christoph Korenke, Tomáš Honzík, Diane Beysen, Frank W. G. Leebeek, Paul A. Skehel, Maartje van den Biggelaar, Tom Carter, Ruben Bierings
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 12, 2026, 20:44Honoring Marion Stolte’s Lasting Impact on the Bleeding Disorders Community – WFH
-
Mar 12, 2026, 20:37Paul Riley: Is Thrombin Generation Assay Ready for Prime Time?
-
Mar 12, 2026, 20:28Rob Maloney: Building Visibility for Bleeding Disorders in Rural Georgia
-
Mar 12, 2026, 20:19Akshat Jain: Validating Oral Pain Medication Use as a Global Marker in Sickle Cell Disease
-
Mar 12, 2026, 20:13Michael Makris: Early Clinical Results of AAV8-BDD FVIII Gene Therapy in Hemophilia A
-
Mar 12, 2026, 20:02Wolfgang Miesbach: From Heparin to Vaccines – The Expanding Biology of Anti-PF4 Immunothrombosis
-
Mar 12, 2026, 19:56Christophe Dubois: Celebrating Nicolas Gendron’s HDR Defense and Future in Hemostasis
-
Mar 12, 2026, 17:06Caitlin Raymond: Managing Crigler–Najjar Syndrome Type 1 Crisis Without a Standard TPE Protocol
-
Mar 12, 2026, 17:03Jan Sloves: Insights on Comprehensive Venous Duplex Imaging at VEITH Symposium 2025